News
Impilo’s portfolio company Decon acquires Acekare - a French-based manufacturer and distributor of mobility assistance solutions
Impilo's portfolio company Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry
Impilo completes the acquisition of Oticon Medical
U.S. FDA has granted accelerated approval of Loargys®
Impilo acquires Oticon Medical from Demant
Impilo closes Fund II at the hard cap of €700 million
KKR and Impilo announce strategic partnership together with management in rare disease platform Immedica Pharma
Read our latest news
Impilo’s portfolio company Decon acquires Acekare – a French-based manufacturer and distributor of mobility assistance solutions
The acquisition of Acekare marks an important step in Decon’s strategic ambition to build a leading European niche mobility platform by adding a complementary product company to its existing offering and establishing a direct presence in the French market
Impilo’s portfolio company Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry
Impilo’s portfolio company Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry
Impilo completes the acquisition of Oticon Medical
We are pleased to announce that Impilo has today completed the acquisition of Oticon Medical from Demant A/S. This marks the first investment in our recently raised Fund II.
U.S. FDA has granted accelerated approval of Loargys®
Immedica today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Loargys® (pegzilarginase-nbln), an arginine specific enzyme indicated for the treatment of hyperargininemia in adult and pediatric patients 2 years of age and older with Arginase 1 Deficiency (ARG1-D), in conjunction with dietary protein restriction.
Impilo acquires Oticon Medical from Demant
Impilo has agreed to acquire Oticon Medical AB, a global leader in bone-anchored hearing solutions (BAHS), from Demant A/S. The transaction is the first investment from Impilo’s new flagship fund and will support Oticon Medical’s transition to a standalone company while driving growth, advancing next-generation technologies, and improving outcomes for people with hearing loss.
Qufora acquires UK medical appliance supplier
Qufora Ltd, a subsidiary of the Danish medtech company Qufora, acquired Rapidcare (The Koppa Company Limited), a UK Dispensing Appliance Contractor (DAC).